ARAnn M. Rashmir-Raven

Ann M. Rashmir-Raven

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ann M. Rashmir-Raven has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mitigation of Antibiotic-Inducted Toxicity in Equine Chondrocytes by Soybean/Glucosamine/Chondroitin Combination

    by Cathleen A. Mochal-King, Ann M. Rashmir, Lowella V. Fortuno, Mark W. Grzanna, Angela Y. Au, Jillian Dougherty, Carmelita G. Frondoza

    Objectives The aim of this study was to evaluate the effect of amikacin (AK) and enrofloxacin (EF) at concentrations consistent with those obtained by intra-articular and intravenous regional limb perfusion on both cytotoxicity and prostaglandin E2 (PGE2) production by equine chondrocytes. This study also determines if PGE2 production could be reduced by avocado/soybean unsaponifiables (ASU), glucosamine (GLU) and chondroitin sulphate (CS). Study Design Chondrocytes were grown in monolayer from the articular cartilage of 12 horses and treated with clinically relevant concentrations of AK and EF, with or without the combination of ASU + GLU + CS. Positive controls consisted of chondrocytes that were activated with lipopolysaccharide (LPS). Chondrocyte response was evaluated using both MTT cytotoxicity assay and immunoassay for PGE2 production. Results Amikacin and EF generated a dose-dependent cytotoxicity. Amikacin induced 90% cell death at a concentration of 25 mg/mL. Enrofloxacin induced 90% cell death at 1.0 mg/mL and 98% cell death at 10 mg/mL (p < 0.05). Amikacin failed to induce PGE2 production at any of the concentrations studied. In contrast, EF and the positive control (LPS) induced PGE2 production at all concentrations. Induction of PGE2 by EF at all concentrations was significantly reduced (p < 0.05) by pre-treatment with ASU + GLU + CS. Conclusions and Clinical Relevance Horses receiving commonly used dosages of AK and EF may benefit from administration of ASU + GLU + CS. The idea for the project was originated by Ann Rashmir. Experimental design was conceived by Carmelita Frondoza, Ann Rashmir and Cathleen Mochal. Acquisition of the data and data analysis were performed by Cathleen A. Mochal-King, Angela Au, Lowella Fortuno, Mark Grzanna, Carmelita Frondoza and Jillian Dougherty. Cathleen Mochal, Carmelita Frondoza and Ann Rashmir interpreted the data and prepared the manuscript. All authors reviewed the manuscript.

  • A review of physical urticarias in the horse

    by A. M. Rashmir‐Raven


  • Hereditary equine regional dermal asthenia (HERDA) in Quarter Horses: A review of clinical signs, genetics and research

    by A. M. Rashmir‐Raven, S. J. Spier

    Summary: Hereditary equine regional dermal asthenia ( HERDA ) results from a genetic mutation which affects the skin and other tissues of Quarter Horses and horses with Quarter Horse lineage. The disease HERDA has an autosomal recessive mode of inheritance and has become a significant concern in the Quarter Horse industry due to the high frequency of heterozygote carriers. Affected homozygous horses appear normal at birth; however, within the first 2 years of life they usually acquire loose, hyperextensible skin and wounds which result in disfiguring scars either spontaneously or from minor trauma. Some severely affected horses also develop haematomas and seromas. Consequently, most affected horses are subjected to euthanasia at an early age. No treatment options other than palliative therapy currently exist. As part of a five panel test ( http://www.aqha.com/News/News-Articles/2013/April/04292013-Genetic-Testing.aspx ) the American Quarter Horse Association presently requires DNA testing for HERDA on all breeding stallions. There are currently no restrictions on registration of horses heterozygous or homozygous for the HERDA mutation. Due to the autosomal recessive nature of the disease, Quarter Horse mares and horses of all breeds from HERDA ‐associated bloodlines should also be tested.


  • Open Access

    Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination

    by Stacy L Ownby, Lowella V Fortuno, Angela Y Au, Mark W Grzanna, Ann M Rashmir-Raven, Carmelita G Frondoza

    Osteoarthritis (OA) is characterized by inflammation, joint immobility, and pain. Non-pharmacologic agents modulating pro-inflammatory mediator expression offer considerable promise as safe and effective treatments for OA. We previously determined the anti-inflammatory effect of an avocado/soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG) combination on prostaglandin E2 (PGE2) production and nuclear factor-kappa B (NF-κB) translocation. The aim of this study was to evaluate the effects of ASU + EGCG on pro-inflammatory gene expression.


  • Ocular findings in Quarter Horses with hereditary equine regional dermal asthenia

    by Cathleen A. Mochal, William W. Miller, A. James Cooley, Robert L. Linford, Peter L. Ryan, Ann M. Rashmir-Raven

    Objective—To compare ocular structures of Quarter Horses homozygous for hereditary equine regional dermal asthenia (HERDA) with those of Quarter Horses not affected by HERDA (control horses) and to determine the frequency of new corneal ulcers for horses with and without HERDA during a 4-year period. Design—Cohort study of ocular structures and retrospective case series of horses with and without HERDA. Animals—The cohort portion of the study involved 10 Quarter Horses with HERDA and 10 Quarter Horses without HERDA; the retrospective case series involved 28 horses with HERDA and 291 horses without HERDA. Procedures—Ophthalmic examinations, Schirmer tear tests, tonometry, corneal pachymetry, histologic examinations, and scanning electron microscopy (SEM) were performed in cohorts of Quarter Horses with and without HERDA. Records were reviewed to determine the incidence of corneal ulcers in horses with and without HERDA during a 4-year period. Results—Corneal thickness of horses with HERDA was significantly less than that of control horses, but tear production of horses with HERDA was significantly greater than that of control horses. Results of SEM revealed zones of disorganized, haphazardly arranged collagen fibrils in corneas of horses with HERDA that were not evident in corneas of control horses. The incidence of corneal ulcers was significantly greater for horses with HERDA than for horses without HERDA during the 4-year period. Conclusions and Clinical Relevance—Alterations in corneal thickness, arrangement of collagen fibers, and incidence of corneal ulcers indicated that abnormalities in horses with HERDA were not limited to the skin.


  • Biomechanical and molecular characteristics of hereditary equine regional dermal asthenia in Quarter Horses

    by Jesse G. Grady, Steven H. Elder, Peter L. Ryan, Cyprianna E. Swiderski, Ann M. Rashmir‐Raven

    Hereditary equine regional dermal asthenia (HERDA) is an autosomal recessive skin disorder that has yet to be fully characterized. HERDA is predominately expressed in Quarter Horses, with the majority of these disseminating from elite cutting horse bloodlines, leading to the increased incidence of HERDA in recent years. Affected horses have loose, hyper-extensible, fragile skin and are frequently euthanized due to poor wound healing and disfiguring scars. This study sought to better characterize HERDA by analysis of the biomechanical parameters of tensile strength, modulus of elasticity, energy to failure and thickness of skin from 10 affected and 6 unaffected horses using an Instron Universal Testing Instrument. In addition, total soluble collagen and glycosaminoglycan concentrations of skin were analysed from 13 affected and 12 unaffected horses using Sircol Soluble Collagen and Blyscan Sulfated Glycosaminoglycan assays respectively. Affected horses exhibited a two to threefold reduction in tensile strength versus unaffected horses with statistically significant differences at six of seven sample locations (P < or = 0.05). The modulus of elasticity proved to be significantly different at six of seven sample locations, energy to failure at six of seven sample locations, and skin thickness at one of seven sample locations (P < or = 0.05). Affected horses exhibited significantly higher amounts of total soluble collagen than unaffected horses (P < or = 0.05). No significant difference was demonstrated between groups for glycosaminoglycan concentration. Affected horses demonstrated uniformly weaker skin across sample locations, indicating the biomechanical properties of HERDA are not regionally confined to specific areas of the horses' skin.


    • 15 September 1999
      • Vol. 215  (6) , 787-9

    Theriogenology question of the month. Septic orchitis-periorchitis and epididymitis.

    by C M Kasaback, A M Rashmir-Raven, S S Black


    • 15 May 1997
      • Vol. 210  (10) , 1421-2

    What is your diagnosis? Chronic sepsis of the distal interphalangeal joint and distal portion of the sesamoid bursa.

    by R Johnson, A M Rashmir-Raven, A W Groce, M W Thomas

    • 1 June 1991
      • Vol. 198  (11) , 1991-2

    What is your diagnosis? Upper airway obstruction in a horse caused by pharyngeal perforation during nasogastric intubation.

    by A M Rashmir-Raven, R M DeBowes, L J Gift, J B Douglass